These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23872903)

  • 1. Update on pathogenesis and treatment of CLE.
    Privette ED; Werth VP
    Curr Opin Rheumatol; 2013 Sep; 25(5):584-90. PubMed ID: 23872903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetics of cutaneous lupus erythematosus.
    Hersh AO; Arkin LM; Prahalad S
    Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
    Stannard JN; Kahlenberg JM
    Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
    Hejazi EZ; Werth VP
    Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.
    Kuhn A; Sigges J; Biazar C; Ruland V; Patsinakidis N; Landmann A; Amler S; Bonsmann G;
    Br J Dermatol; 2014 Sep; 171(3):571-9. PubMed ID: 24673427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
    Carter LM; Wigston Z; Laws P; Vital EM
    Br J Dermatol; 2023 Jul; 189(2):210-218. PubMed ID: 36944572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Lupus Erythematosus: Progress and Challenges.
    Petty AJ; Floyd L; Henderson C; Nicholas MW
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
    Lim D; Kleitsch J; Werth VP
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
    Foulke G; Helm LA; Clebak KT; Helm M
    FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
    Niebel D; de Vos L; Fetter T; Brägelmann C; Wenzel J
    Am J Clin Dermatol; 2023 Jul; 24(4):521-540. PubMed ID: 37140884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lupus erythematosus: diagnosis and management.
    Fabbri P; Cardinali C; Giomi B; Caproni M
    Am J Clin Dermatol; 2003; 4(7):449-65. PubMed ID: 12814335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lupus erythematosus: diagnosis and treatment.
    Okon LG; Werth VP
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):391-404. PubMed ID: 24238695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous lupus.
    Chang AY; Werth VP
    Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.